Get the Stockscreener App
0.85
8.83%
0.069
Dyadic International Inc De stock is traded at $0.85, with a volume of 253.90K.
It is up +8.83% in the last 24 hours and down -13.27% over the past month.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
See More
Previous Close:
$0.781
Open:
$0.805
24h Volume:
253.90K
Relative Volume:
2.52
Market Cap:
$30.76M
Revenue:
$4.14M
Net Income/Loss:
$-5.58M
P/E Ratio:
-4.4737
EPS:
-0.19
Net Cash Flow:
$-2.98M
1W Performance:
+13.59%
1M Performance:
-13.27%
6M Performance:
-42.18%
1Y Performance:
-37.96%
1-Day Range:
$0.80
$0.8896
1-Week Range:
$0.7512
$0.8896
52-Week Range:
$0.711
$2.20
Dyadic International Inc De Stock (DYAI) Company Profile
Name
Dyadic International Inc De
Sector
Industry
Phone
561-743-8333
Address
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.92 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.58 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.53 | 110.24M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1668 | 351.80M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.24 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Downgrade | Dawson James | Buy → Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
Dyadic International Inc De Stock (DYAI) Latest News
Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewswire
Dyadic Applied BioSolutions: Strategic Shift and Financial Growth - TipRanks
Dyadic's Strategic Milestone and Capital Raise: A Catalyst for 2026 Commercialization - AInvest
Earnings call transcript: Dyadic Q2 2025 sees revenue growth, stock dips - Investing.com Nigeria
Earnings call transcript: Dyadic Q2 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa
DYADIC INTERNATIONAL Earnings Results: $DYAI Reports Quarterly Earnings - Quiver Quantitative
Dyadic Transforms from R&D to Commercial Player with Revenue Surge, Multiple Product Launches Coming - Stock Titan
Global Protein Hydrolysis Enzymes Industry Study: Market Analysis 2025-2035 - MarketReports.us
Will earnings trigger a reversal in Dyadic International Inc.2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
Using fundamentals and technicals on KPRXAlgorithmic Prediction of Market Breakouts - Newser
Dyadic International (DYAI) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Should you hold or exit Kilroy Realty Corporation nowShort Term Momentum Based Trading Strategy - Newser
Specialty Enzymes Market to Reach $9.2 Billion by 2029, Driven by Biotech Innovation and Public Funding - GlobeNewswire
Is it time to cut losses on Camtek Ltd.Free Trade Scanner With Buy Zone Alerts - Newser
Dyadic International, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13 - Quiver Quantitative
Dyadic International Earnings: Precision Protein Biotech Leader Reports Q2 Results August 13 - Stock Titan
Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 - GlobeNewswire
Dyadic International Closes $5.3 Million Stock Offering - The Globe and Mail
Is Dyadic International Inc. building a consolidation baseFree Trade Timing Strategy With Technical Data - Newser
UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewswire
Dyadic International prices $5.75 million public offering By Investing.com - Investing.com UK
Dyadic International, Inc. Announces Pricing of $5.75 Million Public Offering of Common Stock - Quiver Quantitative
Economic Sector Performance Dashboards - Yahoo Finance
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewswire
Dyadic International prices public offering of 6 million shares - Investing.com Australia
Dyadic International prices public offering of 6 million shares By Investing.com - Investing.com Canada
Dyadic International Raises Capital: 6 Million Share Offering to Fuel Precision Protein Development - Stock Titan
Dyadic International, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewswire
Dyadic International launches public stock offering; shares down 11.5% - MSN
Dyadic International launches public offering of common stock - Investing.com Australia
Dyadic International Announces Strategic Stock Offering: Biotech Platform Expansion Plans Revealed - Stock Titan
What high frequency data says about PRPLDaily Trade Monitor with Pattern Alerts - Newser
How volatile is Dyadic International Inc. stock compared to the marketAchieve rapid portfolio growth with expert guidance - Jammu Links News
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic International Receives Nasdaq Deficiency Notice - TipRanks
Dyadic International Shifts Focus to Commercial Enterprise - TipRanks
DYAI 8-K: Dyadic Shifts to Commercial Focus With C1 & Dapibus™ Platforms | AIRE SEC FilingForm 8-K - Stock Titan
Dyadic International Receives Nasdaq Deficiency Notice: Compliance Deadline and Potential Delisting - AInvest
Candel Therapeutics Inc. Stock Analysis and ForecastSkyrocketing returns - Jammu Links News
What analysts say about The Real Brokerage Inc. stockOutstanding capital returns - jammulinksnews.com
P 500Short Term Profit Focus - Newser
Why EFC.PRD stock attracts strong analyst attentionStrategic High Profit Opportunities - Newser
Dyadic rebrands as Applied BioSolutions to focus on commercial growth By Investing.com - Investing.com Canada
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions - Yahoo Finance
Dyadic International shareholders approve board proposals at annual meeting - Investing.com
Millennium Management LLC Takes Position in Dyadic International, Inc. (NASDAQ:DYAI) - Defense World
Kopin Co. (NASDAQ:KOPN) Shares Acquired by Bank of America Corp DE - Defense World
Bank of America Corp DE Grows Stock Position in Potbelly Co. (NASDAQ:PBPB) - Defense World
Industrial Enzymes Market worth $12.01 billion by 2030 - MarketsandMarkets
Jane Street Group LLC Has $51,000 Position in Altus Power, Inc. (NYSE:AMPS) - Defense World
Comprehensive Report Reviews the Biotechnology Research Investment Driving Specialty Enzymes Market Growth:... - WhaTech
Dyadic International Inc De Stock (DYAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):